MedPath

An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults

Not Applicable
Not yet recruiting
Conditions
E-cigarette Use
Interventions
Behavioral: Live Free From E-cigarettes
Registration Number
NCT06129123
Lead Sponsor
University of Southern California
Brief Summary

The goal of this intervention development and pilot clinical trial is to determine whether receiving the brief online intervention results in greater reductions in past 7-day e-cigarette use frequency and smoking susceptibility over an 8-week period compared to receiving the control condition in young adults who currently use e-cigarettes. Participants in the experimental condition will be asked to complete the 30-minute mobile-based program. Participants in the assessment-only control will be given the option to access the intervention after they complete their final survey at 8 weeks. All participants will complete our online surveys at baseline as well as 2-weeks, 4-weeks, and 8-weeks post-randomization. Researchers will compare outcomes among the intervention and control groups to determine the efficacy of the intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • be between the ages of 18 to 24
  • be able to read English
  • report vaping at least one day per week in the past month
  • report no history of cigarette use at screening and baseline.
Exclusion Criteria
  • reporting severe mental health, illicit drug use, or alcohol use disorder
  • currently receiving nicotine cessation services

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionLive Free From E-cigarettesParticipants will be asked to complete a 30-minute intervention that is accessible on a mobile device, delivered via a webpage, and personalized to their individual vaping behavior and beliefs (based on the baseline surveys). The intervention will contain personalized normative feedback (PNF), Motivational Enhancement (ME), and education. Participants will complete assessments at baseline as well as 2-weeks, 4-weeks, and 8-weeks post randomization.
Primary Outcome Measures
NameTimeMethod
E-cigarette Use8 weeks

Participants will report the number of (1) days they vaped, (2) times they picked up their device to vape per day, and (3) puffs they took before putting their vaping device away per day in the past 7 days and 30 days

Smoking Susceptibility8 weeks

4-item Expanded Susceptibility to Smoking Index (ESSI)

Secondary Outcome Measures
NameTimeMethod
Perceived harms and benefits of vaping8 weeks

Using the 21-item Short Form Vaping Consequences Questionnaire (S-VSQ), participants will rate the likelihood that each consequence will occur when they vape.

Perceived harms and benefits of smoking8 weeks

Using the 21-item Short Form Smoking Consequences Questionnaire (S-SCQ), participants will rate the likelihood that each consequence will occur when they smoke.

Motivation to vape8 weeks

Participants will select which option best describes their interest in e-cigarette use: plan to stop (coded as 1), decrease (2), continue (3) or increase (4) vaping.

Motivation to smoke8 weeks

Participants will report if they plan to start smoking (yes/no).

Quitting vaping self-efficacy8 weeks

Participants rate their confidence about quitting vaping "someday" and "in the next 6 months" on a 5-point scale.

Vaping quit attempts8 weeks

During follow-up assessments, participants will report on the number of times they have stopped vaping for one day or longer because they were trying to quit vaping.

© Copyright 2025. All Rights Reserved by MedPath